EBSCO Logo
Connecting you to content on EBSCOhost
Title

SGLT2 inhibitors and their association with balanoposthitis and Fournier's gangrene.

Authors

Seidu, Sam

Abstract

A 57-year-old male patient of the author recently presented with balanoposthitis and penile cellulitis, at risk of progressing to Fournier's gangrene. The man, who was diagnosed with type 2 diabetes 5 years ago, had recently been prescribed a sodium--glucose cotransporter-2 (SGLT2) inhibitor as an addition to metformin 2 g daily and gliclazide 160 mg daily. This case serves as a reminder of this rare condition, its association with SGLT2 inhibitors and the importance of taking urgent action if it is suspected in a patient.

Subjects

ANTIBIOTICS; PENIS diseases; FOURNIER gangrene; SODIUM-glucose cotransporters; GLYCEMIC control; DISEASE risk factors

Publication

Diabetes & Primary Care, 2020, Vol 22, Issue 2, p31

ISSN

1466-8955

Publication type

Academic Journal

EBSCO Connect | Privacy policy | Terms of use | Copyright | Manage my cookies
Journals | Subjects | Sitemap
© 2025 EBSCO Industries, Inc. All rights reserved